Dr. Julia Haller from Wills Eye Institute comments on ocriplasmin’s potential to become the first pharmacologic option to treat symptomatic vitreomacular adhesions, and how it could affect practice.
Dr. Roger Steinert comments on the need for change in the medical device industry so that technologic advances can become available more quickly to better care for patients. Learn how to help.
Dr. Roger Steinert touches on a few of the hot topics and innovative content available at this year's American Academy of Ophthalmology (AAO) meeting.
Dr. Smith from CDC reviews the history that should tip you off to potential fungal endophthalmitis.
In case you missed it, Dr. Christopher Rapuano from the Wills Eye Institute recaps the latest information and emerging trends in cornea and external disease from this year's meeting.
Dr. Alex Levin from the Wills Eye Institute explains how the field of ocular genetics might change the future for patients with hereditary disease.
Retinal specialists from the Wills Eye Institute discuss progress in the treatment of AMD, retinal vein occlusion, and vitreoretinal disease.
Surgeons experienced in femtosecond laser cataract surgery discuss their involvement with the procedure and try to imagine future possibilities.
Exciting developments in the treatment of retinal diseases were unveiled at this year's meeting.
Glaucoma specialists discuss the latest innovations in the diagnosis and management of glaucoma and whether the latest toy is necessary.